Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
- PMID: 16518829
- PMCID: PMC7169118
- DOI: 10.1002/rmv.492
Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
Abstract
SARS-CoV is a new type of human coronavirus identified as a causative agent of severe acute respiratory syndrome (SARS). On the occasion of the SARS outbreak, various monoclonal antibodies (mAbs) against SARS-CoV have been developed and applied for diagnosis, clinical management and basic research. In this review, we overview the biochemical and functional properties and applications of these SARS-CoV mAbs. We also focus on a variety of vaccines currently under development and discuss the immune response elicited by these vaccines in animal models, hopefully to better understand what we need to do next to fight against newly emerging pathogens in the future.
2006 John Wiley & Sons, Ltd.
Similar articles
-
Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.Curr Opin Mol Ther. 2005 Apr;7(2):151-6. Curr Opin Mol Ther. 2005. PMID: 15844623 Review.
-
Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.Clin Vaccine Immunol. 2007 Jul;14(7):894-901. doi: 10.1128/CVI.00019-07. Epub 2007 May 9. Clin Vaccine Immunol. 2007. PMID: 17494640 Free PMC article.
-
The possible of immunotherapy for COVID-19: A systematic review.Int Immunopharmacol. 2020 Jun;83:106455. doi: 10.1016/j.intimp.2020.106455. Epub 2020 Apr 2. Int Immunopharmacol. 2020. PMID: 32272396 Free PMC article.
-
Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).Virology. 2005 Mar 30;334(1):134-43. doi: 10.1016/j.virol.2005.01.035. Virology. 2005. PMID: 15749129 Free PMC article.
-
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.J Gen Virol. 2008 Sep;89(Pt 9):2136-2146. doi: 10.1099/vir.0.2008/001891-0. J Gen Virol. 2008. PMID: 18753223
Cited by
-
Application of Traditional Vaccine Development Strategies to SARS-CoV-2.ArXiv [Preprint]. 2023 Jan 23:arXiv:2208.08907v2. ArXiv. 2023. Update in: mSystems. 2023 Apr 27;8(2):e0092722. doi: 10.1128/msystems.00927-22. PMID: 36034485 Free PMC article. Updated. Preprint.
-
Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.Biochem Pharmacol. 2008 Apr 15;75(8):1601-9. doi: 10.1016/j.bcp.2008.01.005. Epub 2008 Jan 19. Biochem Pharmacol. 2008. PMID: 18313035 Free PMC article.
-
An overview of viruses discovered over the last decades and drug development for the current pandemic.Eur J Pharmacol. 2021 Jan 5;890:173746. doi: 10.1016/j.ejphar.2020.173746. Epub 2020 Nov 19. Eur J Pharmacol. 2021. PMID: 33221318 Free PMC article. Review.
-
SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.J Med Virol. 2021 Feb;93(2):892-898. doi: 10.1002/jmv.26320. Epub 2020 Oct 5. J Med Virol. 2021. PMID: 32691875 Free PMC article.
-
Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus.Antiviral Res. 2006 Nov;72(2):78-88. doi: 10.1016/j.antiviral.2006.05.010. Epub 2006 Jun 6. Antiviral Res. 2006. PMID: 16820226 Free PMC article. Review.
References
-
- Marra MA, Jones SJ, Astell CR, et al The genome sequence of the SARS‐associated coronavirus. Science 2003; 300: 1399–1404. - PubMed
-
- Rota PA, Oberste MS, Monroe SS, et al Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394–1399. - PubMed
-
- Li G, Chen X, Xu A. Profile of specific antibodies to the SARS‐associated coronavirus. N Engl J Med 2003; 349: 508–509. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous